Literature DB >> 6440414

Detection of proteases of Pseudomonas aeruginosa in immune complexes isolated from sputum of cystic fibrosis patients.

G Döring, V Buhl, N Høiby, P O Schiøtz, K Botzenhart.   

Abstract

Sera and sputa of 12 cystic fibrosis patients suffering from chronic Pseudomonas aeruginosa lung infections were assayed for immune complexes using the Raji cell assay. Whereas all sera were negative, 33% of the sputa were positive for immune complexes. Sera and sputa of these patients were also assayed for antibodies against P.aeruginosa alkaline protease (AP) and elastase (Ela) and sputa for AP and Ela, using radioimmunoassays. All patients revealed antibody titers to the proteases in serum (1:5-1:1000) and eight patients had antibody titers to the proteases in sputum (1:5-1:100); all sputa were negative for AP and Ela. Sputum immune complexes and IgG were separated from whole sputum on a Protein A-Sepharose C1-4B column and treated with 0.75 M 2-mercaptoethanol and iodoacetamide after elution. After treatment, 58% of the sputa were positive for AP and/or Ela (5-200 ng/ml sputum). The present study shows that proteases of P.aeruginosa are bound in immune complexes after the initiation of the immune response to these antigens and it yields new insights into the role of these proteases in chronic lung infection in cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6440414     DOI: 10.1111/j.1699-0463.1984.tb00092.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand C        ISSN: 0108-0202


  13 in total

Review 1.  Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.

Authors:  N Høiby; C Koch
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

2.  Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.

Authors:  M F Tosi; H Zakem; M Berger
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

Review 3.  Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis.

Authors:  N Høiby
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

4.  Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis.

Authors:  T R Anderson; T C Montie; M D Murphy; V P McCarthy
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

Review 5.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

6.  Renal function in cystic fibrosis: proteinuria and enzymuria before and after tobramycin therapy.

Authors:  G Steinkamp; M Lütge; U Wurster; J G Schulz-Baldes; H J Gröne; J H Ehrich
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

7.  Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis.

Authors:  G Döring; W Goldstein; A Röll; P O Schiøtz; N Høiby; K Botzenhart
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

8.  Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease.

Authors:  G Döring; W Goldstein; K Botzenhart; A Kharazmi; P O Schiøtz; N Høiby; M Dasgupta
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

9.  [Significance of Pseudomonas aeruginosa virulence factors for acute and chronic Pseudomonas aeruginosa infections].

Authors:  G Döring
Journal:  Infection       Date:  1987       Impact factor: 7.455

10.  Population transcript accumulation of Pseudomonas aeruginosa exotoxin A and elastase in sputa from patients with cystic fibrosis.

Authors:  D G Storey; E E Ujack; H R Rabin
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.